Urbanowski Eric D - IL Kankakee, Manteno 60950

Urbanowski Eric D entered the industry of Science of Mind Practitioners in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6213300, which describes it as a Science of Mind Practitioners. For further clarification, the SIC classifies this business under the code 8049 and described it as a Science of Mind Practitioners. The business provides service to the B2C market.

To acquire more information, please contact Eric Urbanowski by calling (815) 468-0190 during business hours. You can also write to the business’ Single Location at 47 South Locust St, Manteno, Illinois IL 60950. You can also visit the company’s website at docsdrugs.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Urbanowski Eric D
Representative: Eric Urbanowski
Place of Business: 47 South Locust St, Manteno, IL 60950
Contact Number: (815) 468-0190
Website: docsdrugs.com
Type of Service: Science of Mind Practitioners
SIC Number: 8049
NAICS Number: 6213300
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Urbanowski Eric D is a company operating from Kankakee, Illinois providing professional Science of Mind Practitioners and relevant B2C variables. It was founded in 0 and registered with the SIC code 8049 as Science of Mind Practitioners, and with the NAICS code 6213300 as Science of Mind Practitioners.

With a current employee count of 1 to 4, Urbanowski Eric D has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Eric Urbanowski at (815) 468-0190 for related queries, or to locate its Single Location using the coordinates 41.24751,-87.83355.

The Single Location can also be found at the street address 47 South Locust St in Manteno, Illinois 60950 and can be engaged online through the company website at docsdrugs.com, the company Twitter , and Facebook page .